I. Department of Medicine, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.
Protozoa Immunology, Bernhard Nocht Institute for Tropical Medicine, 20359 Hamburg, Germany.
Cells. 2023 Jan 17;12(3):341. doi: 10.3390/cells12030341.
Nonalcoholic fatty liver disease (NAFLD) is the most common liver pathology worldwide. In mice and humans, NAFLD progression is characterized by the appearance of TREM2-expressing macrophages in the liver. However, their mechanistic contributions to disease progression have not been completely elucidated. Here, we show that TREM2 macrophages prevent the generation of a pro-inflammatory response elicited by LPS-laden lipoproteins . Further, expression regulates bone-marrow-derived macrophages (BMDMs) and Kupffer cell capacity to phagocyte apoptotic cells , which is dependent on CD14 activation. In line with this, loss of resulted in an increased pro-inflammatory response, which ultimately aggravated liver fibrosis in murine models of NAFLD. Similarly, in a human NAFLD cohort, plasma levels of TREM2 were increased and hepatic expression was correlated with higher levels of liver triglycerides and the acquisition of a fibrotic gene signature. Altogether, our results suggest that TREM2 macrophages have a protective function during the progression of NAFLD, as they are involved in the processing of pro-inflammatory lipoproteins and phagocytosis of apoptotic cells and, thereby, are critical contributors for the re-establishment of liver homeostasis.
非酒精性脂肪性肝病(NAFLD)是全球最常见的肝脏病理学。在小鼠和人类中,NAFLD 的进展特征是肝脏中出现表达 TREM2 的巨噬细胞。然而,它们对疾病进展的机械贡献尚未完全阐明。在这里,我们表明 TREM2 巨噬细胞可防止由负载 LPS 的脂蛋白引发的促炎反应。此外,表达调节骨髓来源的巨噬细胞(BMDM)和枯否细胞吞噬凋亡细胞的能力,这依赖于 CD14 的激活。与此一致,的缺失导致促炎反应增加,最终在 NAFLD 的小鼠模型中加重了肝纤维化。同样,在人类 NAFLD 队列中,TREM2 的血浆水平升高,肝内表达与更高水平的肝甘油三酯和获得纤维化基因特征相关。总之,我们的结果表明,TREM2 巨噬细胞在 NAFLD 的进展过程中具有保护功能,因为它们参与了促炎脂蛋白的处理和凋亡细胞的吞噬作用,因此是重新建立肝脏内稳态的关键贡献者。
Free Radic Biol Med. 2024-8-1
Proc Natl Acad Sci U S A. 2024-8-27
Cells. 2020-12-7
Immunol Cell Biol. 2023-3
Parasit Vectors. 2025-7-1
J Leukoc Biol. 2025-9-1
Front Aging Neurosci. 2025-5-1
Trends Endocrinol Metab. 2025-5-13
Front Immunol. 2025-4-2
Hepatol Commun. 2024-11-15
Biomark Res. 2024-11-4
Mol Metab. 2021-8